CLOV vs OCGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CLOV

34.3
AI Score
VS
OCGN Wins

OCGN

44.8
AI Score

Investment Advisor Scores

CLOV

34score
Recommendation
SELL

OCGN

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV OCGN Winner
Forward P/E 81.9672 13.0719 OCGN
PEG Ratio 0 0 Tie
Revenue Growth 55.6% 8.4% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 34.3/100 44.8/100 OCGN
Profit Margin -0.7% 0.0% OCGN
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD OCGN

Relative Price Performance (Last 90 Days)

CLOV 1M: +0.0% · 3M: +1.2% OCGN 1M: +15.1% · 3M: -2.8%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $4.23

OCGN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.3% over 20 days), RSI 51

RSI (14): 51.3 · Price: $1.37

Fundamentals Snapshot

Metric CLOV OCGN
Market Cap
Forward P/E 28.2 -5.1
Trailing P/E
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 0.2% -8.6%
Operating Margin 0.0% -11.1%
EPS -0.05 -0.26
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, OCGN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.